Tata Chemicals Plans to Raise Rs 1,000 Crore via Debentures
Tata Chemicals has sought shareholders nod to raise up to Rs 1,000 crore from private placement of non-convertible debentures for general corporate purposes.
According to the agenda for the company's AGM (annual general meeting) scheduled for August 21, Tata Chemicals has moved a special resolution for authorizing its Board to raise up to Rs 1,000 crore via debentures.
"The approval of shareholders members be and is hereby accorded to authorize the board of directors of the Company ('the Board') to offer or invite subscriptions for Redeemable Non-Convertible Debentures, in one or more tranches, such that aggregate amount does not exceed Rs 1,000 crore on private placement...," as per the agenda of AGM meeting.
Elaborating the rationale behind moving such resolution, Tata Group firm said it will raise the amount for augmentation of long term resources.
The agenda noted added: "In order to augment the long term resources for financing and for general corporate purposes, the Company may offer or invite subscriptions for Nonconvertible Debentures in one or more tranches on private placement, issuable/redeemable at par."
The company has also moved a resolution for the approval of the borrowing limits to up to Rs 5,500 crore.
In another resolution, it has also sought shareholders nod for reappointment of R Mukundan as managing director of the company for five years till November 25, 2018, including remuneration and other terms of the employment.
Meanwhile board has already approved the reappointment of Mukundan as the company's managing director.
In five different resolutions, the company has also sought shareholders nod for reappointment of Nusli Wadia, Vijay Kelkar, Nasser Munjee, Eknath Kshirsagar and Y S P Thorat as independent directors of the company.
Tata Chemical's first quarter earnings of the current fiscal 2014-15 are scheduled for August 5.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.